Cancer and COVID-19: Dr. David Ryan Talks with Dr. Alyssa Letourneau
In this video, Dr. Alyssa Letourneau discusses the antiviral Remdesivir, how it was developed, and the clinical trials that are taking place to test the drug.
Alyssa R. Letourneau, MD, MPH received an Sc.B. in neuroscience from Brown University and an M.D. from Yale University School of Medicine. She subsequently completed her residency in internal medicine and pediatrics at Massachusetts General Hospital and a fellowship in infectious diseases at Massachusetts General Hospital and Brigham & Women's Hospital. During her training, she received the Edward Kass Award for Clinical Excellence from the Massachusetts Infectious Disease Society and she completed her Master of Public Health at Harvard School of Public Health. She completed an additional year of clinical training in caring for immunocompromised hosts at Brigham & Women's Hospital and the Dana-Farber Cancer Institute.
Dr. Letourneau is the Director of the Massachusetts General Hospital Antimicrobial Stewardship Program and cares for patients both inpatient and in the clinic. Her clinical interest is seeing immunocompromised hosts including patients with leukemia, lymphoma, those who have undergone stem cell transplant as well as patients who will undergo immune modulating therapy.
In 2015, Dr. Letourneau was awarded the Morton N. Swartz Transformative Scholar Award from the Massachusetts General Hospital Division of Infectious Diseases to study respiratory syncytial virus (RSV) in immunocompromised hosts.
Clinical Interests:
Treats:
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
Phone: 617-726-3906
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
An integral part of one of the world’s most distinguished academic medical centers, the Cancer Center is among the leading U.S. cancer care providers.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2023-2024.
In this video, Dr. Alyssa Letourneau discusses the antiviral Remdesivir, how it was developed, and the clinical trials that are taking place to test the drug.